IRCT2014062916229N3已完成3 期
The impact of allopurinol versus placebo in patients with acute ST elevation myocardial infarction undergoing fibrinolytic therapy with streptokinase
Vice chancellor for research,, Tabriz University of Medical Sciences0 个研究点目标入组 146 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 146
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 90 years（—）
- 性别
- All
入选标准
- •Patients with first acute STEMI who are candidates for fibrinolytic therapy
- •Exclusion criteria: Patients with firs acute STEMI who are candidates for Primary PCI, Patients with previous myocardial infarction or Primary valvular disease
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Comparison of the therapeutic effect of allopurinol versus placebo on clinical signs and symptoms in patients with manic bipolar disorderManic bipolar disorder.Manic episodeIRCT201710089014N193Vice-chancellor for Research and Technology, Zahedan University of Medical Sciences60
进行中（未招募）
1 期
Estudio para valorar el efecto sobre las plaquetas del tratamiento con Alopurinol en pacientes diabéticosEUCTR2011-000619-16-ESFundación Investigación Biomedica. Hospital Clinico San Carlos
已完成
3 期
Comparison of the effectiveness of allopurinol and placebo in reducing depressive symptoms in patients with major depressive disorderIRCT201508277373N6Arak University of Medical Sceinces70
已完成
3 期
Evaluation of allopurinol efficacy in patients with nonalcoholic fatty liver diseasenonalcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedIRCT20160920029889N1Oroumia University of Medical Sciences44
已完成
不适用
Assessing Allopurinol Effect on Metabolic Acidosis in Patients with Chronic renal failure stage 2-4Condition 1: CKD. Condition 2: CKD stage 2-4.Kidney damage with mild decreased GFR (60-89 mL/minN18.2-N18.Chronic kidney diseaseIRCT2016122731604N1Mashhad University Of Medical Siences50